Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy

Sep.14
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.

Key Points

  • Shenzhen Smoore Technology and distributors Jupiter Research, Greenlane Holdings, 3Win and Canna Brand Solutions are seeking dismissal of the direct purchasers' per se horizontal conspiracy claim.
  • Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on discounting among authorized distributors; the allegations have not been established by the court.
  • Smoore argues that the arrangements were vertical distribution practices between a manufacturer and individual distributors, not an automatically unlawful agreement among competitors.
  • The litigation forms part of a broader CCELL antitrust MDL; the current motion targets a core claim in the direct-purchaser case rather than seeking dismissal of the entire MDL.

2Firsts

September 14, 2026

According to Law360 on September 10, 2026, Shenzhen Smoore Technology Co., Ltd. and four authorized U.S. distributors of CCELL products have asked a California federal court to permanently dismiss a core antitrust class claim brought by direct purchasers, arguing that the alleged pricing and customer arrangements reflect vertical dealings between a manufacturer and distributors rather than a horizontal price-fixing conspiracy.

The motion was filed on September 4 in the U.S. District Court for the Northern District of California.

The litigation is part of In re: CCell Closed Cannabis Oil Vaporization Systems and Components Products Antitrust Litigation, case No. 3:25-md-03161, before U.S. District Judge Vince Chhabria.

Plaintiffs Allege Minimum Pricing and Customer Allocation

The current dispute involves a second amended consolidated class action complaint brought by direct purchasers Meridian Partners II LLC and Redbud Roots Inc.

Along with Smoore, the defendants include four authorized CCELL distributors: Jupiter Research LLC, Greenlane Holdings Inc., 3Win Corp. and CB Solutions LLC, which does business as Canna Brand Solutions.

The plaintiffs allege that Smoore used its position in the cannabis vaping hardware market to organize and enforce pricing and customer arrangements among its authorized distributors.

According to the complaint, distributors agreed to minimum wholesale prices, refrained from competing for certain customers and avoided undercutting one another on price. Plaintiffs also allege that Smoore required authorized distributors to sell only CCELL products and barred them from carrying rival vaping products.

The plaintiffs seek to characterize the arrangements as a horizontal agreement among competitors subject to the Sherman Act's per se rule, under which certain forms of price-fixing and customer allocation can be treated as unlawful without a broader inquiry into market effects.

Those allegations have not been established by the court.

Smoore Says Conduct Was Vertical Distribution Management

Smoore and the four distributors dispute that characterization.

In their dismissal motion, the defendants argue that the second amended complaint still describes separate business relationships between Smoore and individual distributors rather than an agreement among the distributors themselves.

They characterize the alleged arrangements as textbook vertical conduct and say the documents cited by the plaintiffs show how Smoore operated its distribution system, not that competing distributors reached a horizontal agreement.

The distinction matters to the antitrust analysis.

Price-fixing or customer-allocation agreements among competitors can fall within the per se rule, while restrictions imposed in vertical manufacturer-distributor relationships generally require a broader assessment of their competitive effects.

The central dispute is therefore whether CCELL's U.S. distribution structure amounted to vertical channel management or whether Smoore coordinated a horizontal agreement among distributors.

2018 Meeting Again Cited by Plaintiffs

The latest complaint also relies on allegations concerning a 2018 meeting involving the defendants as evidence of coordination among distributors.

Smoore and the distributors argue that the meeting allegations had previously been presented to the court and still do not establish a horizontal agreement.

The defendants are also asking the court not to give the plaintiffs another opportunity to amend the claim.

The court previously dismissed a similar per se horizontal conspiracy claim brought by the direct purchasers. That ruling did not terminate the broader CCELL multidistrict litigation.

Proposed Class Reaches Back to at Least 2016

The proposed direct-purchaser class seeks to represent buyers of unfilled CCELL vaporization systems and components in the United States and its territories from at least December 1, 2016, through the period in which the alleged effects of the purported conspiracy continued.

The plaintiffs seek nationwide relief, including treble damages, attorneys' fees and injunctive relief.

The larger MDL also includes similar claims brought by consumers and other indirect purchasers.

The cases were centralized in the Northern District of California for coordinated proceedings and involve allegations concerning CCELL pricing, distribution restrictions, competing products and relationships among market participants.

The September 4 motion therefore does not seek dismissal of the entire MDL. It targets the direct purchasers' renewed per se horizontal conspiracy theory.

CCELL Distribution Practices Face Antitrust Test

CCELL is one of Smoore's major hardware brands serving cannabis-oil vaporization applications.

The litigation places several common channel-management practices under U.S. antitrust scrutiny, including minimum pricing, customer boundaries among authorized distributors and restrictions involving competing products.

The plaintiffs contend that those practices went beyond separate manufacturer-distributor relationships and became a Smoore-coordinated horizontal arrangement among distributors. Smoore is asking the court to treat the conduct as vertical distribution management and dismiss the per se claim.

The court's handling of the second amended complaint and the latest dismissal motion will determine whether the direct purchasers can continue pursuing this part of the case under a horizontal price-fixing and customer-allocation theory.

Follow 2Firsts for timely updates on global tobacco and nicotine industry developments, corporate strategy and market trends.

Cover Image: ccell

Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's Four-Year Tobacco Tax Plan Heads to Parliament as BAT, JTI and PMI Push for Changes
Germany's parliament is scheduled to hold a first reading of amendments to the Tobacco Tax Act on September 24. The government plans annual tax increases from 2027 through 2030 covering cigarettes, heated tobacco, vaping liquids and other categories. It expects the reform to generate €756 million in additional revenue in 2027, rising to €3.589 billion in additional annual revenue by 2030. Ahead of the parliamentary debate, the German Association of the Tobacco Industry and Novel Products, or BVTE, launched the "Tabaksteuer mit Augenmaß" campaign backed by BAT, JTI, Philip Morris, Reemtsma and wholesale and retail groups.
Sep.23
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
The UK’s Vaping Products Duty and Vaping Duty Stamps Scheme will take effect on October 1, 2026. All vaping liquids manufactured in or imported into the UK will face a flat excise duty of £2.20 per 10ml, whether or not they contain nicotine. Newly manufactured or imported products released onto the UK market from October 1 will require a valid duty stamp, while eligible existing unstamped inventory can continue to be sold through March 31, 2027. From April 1, 2027, all vaping products outside duty suspension must carry a valid stamp.
Sep.03
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14